Vaccine News and Research

Latest Vaccine News and Research

Robots can play a major role in COVID-19 battle

Robots can significantly help in the fight against the coronavirus disease (COVID-19) that is spreading across the globe. As the number of cases tops one million, and the death toll reaching 53,000, scientists race to develop a drug or vaccine for the infectious disease. Now, robots are playing a major role in this fight, improving the health and safety of individuals and patients.

2 Apr 2020

Bayreuth expert presents reliable coronavirus analyses through data assimilation

Thanks to methods used in fluid mechanics, the course of a pandemic and the effectiveness of government containment measures can be assessed promptly and accurately, and forecasts can be derived.

2 Apr 2020

Scientists find important clues to vaccine in SARS-CoV-2 genome

A new research paper published by scientists at the University of Bristol who sequenced the genome of the SARS-CoV-2 virus, which is causing the worldwide COVID-19 illness, reveals some significant findings that could help researchers working on rolling out vaccines to stop the relentless march of the virus. The study was published online on the preprint site bioRxiv in April 2020.

2 Apr 2020

Promising vaccine patch candidate for COVID-19

In a breath of fresh air, scientists from the University of Pittsburgh School of Medicine reported that they had developed a potential new vaccine against the SARS-CoV-2 virus, which is causing the current COVID-19 pandemic. The vaccine has been tested in mice. When administered through a small patch only the size of a fingertip, the vaccine was found to generate protective neutralizing antibodies against the virus, in adequate quantities.

2 Apr 2020

CAS releases new open access COVID-19 Antiviral Candidate Compounds Dataset

CAS, a division of the American Chemical Society specializing in scientific information solutions, is partnering with research and technology organizations worldwide to tackle the complex challenges presented by COVID-19.

2 Apr 2020

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

OXGENE™ and The Native Antigen Company today announced a collaboration to scale up production of SARS-CoV-2 (COVID-19) reagents.

2 Apr 2020

Study looks at Russian trolls that polarize vaccination efforts

There has always been controversy surrounding vaccines, but in the past, that was usually overridden by fear of the disease itself. The diseases vaccines prevent can be dangerous or even deadly. However, many anti-vaccination groups add to the confusion of people on the benefits of immunization against infectious diseases.

2 Apr 2020

What are coronaviruses and COVID-19?

The current COVID-19 pandemic is caused by a novel coronavirus called SARS-CoV-2, or severe acute respiratory syndrome coronavirus 2. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2.

1 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

Phoseon’s KeyPro products use high-intensity UV light to fight against pathogens

Phoseon’s KeyPro™ family of products uses high-intensity, deep ultraviolet light to disinfect and decontaminate laboratory equipment and surfaces. Independent testing has shown efficacy of KeyPro against viruses, bacteria, fungi, and biomolecules like ribonuclease.

From Phoseon Technology 1 Apr 2020

Blood centers will collect plasma from COVID-19 survivors in bid for treatment

Blood donation centers across the U.S. are ramping up efforts to collect plasma from people who have recovered from COVID-19 in hopes it could be used to save the lives of others infected with the pandemic disease.

1 Apr 2020

Purdue scientists working to speed up diagnostic, therapeutic solutions for COVID-19

As the coronavirus pandemic spreads across the U.S. and the world, Purdue University scientists are working to move solutions to diagnose and treat the virus to the marketplace as soon as possible.

1 Apr 2020

Spit and feces test positive for SARS CoV-2 even after recovery

A new study reveals that samples of sputum and feces continue to test positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus even after a person has recovered from COVID-19 and nasopharyngeal secretions test negative for the virus.

31 Mar 2020

UM receives funding for research center dedicated to addressing public health challenges

As emergent pathogens like coronavirus and climate-related health challenges like wildfire smoke plague human populations, the University of Montana has received funding for a center dedicated to understanding and addressing public health challenges to Montana and the region.

31 Mar 2020

Novel, affordable pneumonia vaccine tested in human patients

A novel vaccine against pneumonia that is less expensive and more effective than those currently used in Brazil is being tested in human patients.

31 Mar 2020

Virus-scanning tool could identify previously undetected cases of COVID-19 infections

When a virus invades the body, it leaves fingerprints behind. A research tool known as VirScan can detect this evidence - from just a single drop of blood - and identify the viruses that have infected a person in the past. Soon, the new coronavirus will join the VirScan lineup.

31 Mar 2020

Three Australian experts explain the course of COVID-19

Researchers have been studying the ongoing pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely since its beginning in December 2019. To date, the virus has infected over 850,000 individuals across the globe and killed over 41,000.

31 Mar 2020

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet, one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic.

31 Mar 2020

Online coronavirus tests are just the latest iffy products marketed to anxious consumers

Companies with experience in the "at-home" testing market began announcing in mid-March that they would be offering direct-to-consumer test kits for COVID-19.

31 Mar 2020

Eight strains of coronavirus afflicting the world

Scientists around the world are racing to study the novel coronavirus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, it appears that there are eight strains of SARS-CoV-2 circulating the globe. The good news is that according to infectious disease physician and clinical microbiologist Charles Chiu, “The virus mutates so slowly that the virus strains are fundamentally very similar to each other.”

31 Mar 2020

Vaccine News and Research

Latest Vaccine News and Research

Robots can play a major role in COVID-19 battle

Bayreuth expert presents reliable coronavirus analyses through data assimilation

Scientists find important clues to vaccine in SARS-CoV-2 genome

Promising vaccine patch candidate for COVID-19

CAS releases new open access COVID-19 Antiviral Candidate Compounds Dataset

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

Study looks at Russian trolls that polarize vaccination efforts

What are coronaviruses and COVID-19?

Putting an end to the pandemic

Phoseon’s KeyPro products use high-intensity UV light to fight against pathogens

Blood centers will collect plasma from COVID-19 survivors in bid for treatment

Purdue scientists working to speed up diagnostic, therapeutic solutions for COVID-19

Spit and feces test positive for SARS CoV-2 even after recovery

UM receives funding for research center dedicated to addressing public health challenges

Novel, affordable pneumonia vaccine tested in human patients

Virus-scanning tool could identify previously undetected cases of COVID-19 infections

Three Australian experts explain the course of COVID-19

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

Online coronavirus tests are just the latest iffy products marketed to anxious consumers

Eight strains of coronavirus afflicting the world

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in